Top 20 Companies in Global Dyslexia Treatment and Diagnosis Market: Statistics Report Till 2035

Introduction

The global dyslexia treatment and diagnosis market refers to the educational programs, cognitive programs, technologies, and therapies designed to help dyslexics overcome their learning challenges. This also includes professional diagnostic assessments, tutoring programs, and advanced technologies that help in brain plasticity, thus helping to diagnose and treat dyslexia in patients across the global market. The key applications include the development of digital therapeutics, mobile apps for personalization, gamification, and reading interventions, assistive technologies for comprehension, and teletherapy for remote diagnosis, early interventions, and increased accessibility, scalability, and efficacy of treatments.

 

The high global prevalence of dyslexia, affecting approximately 15-20% of the population (around 780 million individuals), significantly expands the addressable patient pool, driving sustained demand for diagnostic services, assistive technologies, and therapeutic interventions, thereby accelerating market growth.

 

The innovations such as AI-driven diagnostics, digital therapeutics, and assistive technologies. There are opportunities in personalized learning platforms, telehealth expansion, and neurofeedback technologies that will provide a scope for scalability and data-driven solutions in a more accessible manner. Inclusion of holistic support systems will provide a positive impact on long-term outcomes and thereby attract more investments in this market segment.

 

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Dyslexia Treatment and Diagnosis Market

 

Dyslexia Treatment and Diagnosis Market & Statistics

• The Market Size for Dyslexia Treatment and Diagnosis Market Was Estimated to be worth USD 28.91 billion in 2024.
• The Market Size is Going to Expand at a CAGR of 7.62% between 2025 and 2035.
• The Global Dyslexia Treatment and Diagnosis Market Size is anticipated to reach USD 64.83 billion by 2035.
• North America is estimated to generate the highest demand during the forecast period in the Global Dyslexia Treatment and Diagnosis Market.
• Asia Pacific is projected to grow the fastest during the forecast period in The Global Dyslexia Treatment and Diagnosis Market.

 

 

Market Segmentation

Global Dyslexia Treatment and Diagnosis Market Size, Share, By Type (Phonological Dyslexia, Surface Dyslexia, Double Deficit Dyslexia, Others), By Drug Class (Antihistamines, Central Nervous Stimulant, Selective Norepinephrine Reuptake Inhibitors, Others), By End User (Psychiatric Institutions, Rehabilitation Centres, Home Care, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

 

Regional growth and demand

Asia‑Pacific is expected to grow the fastest during the forecast period in the dyslexia treatment and diagnosis market. It is because of increasing awareness about learning disabilities, improvements in healthcare and educational infrastructure, and the rise in early screening programs led by governments are also contributing to the growth in this region. The high rate of urbanization, large pediatric population size, and increasing investments in digital diagnostic and therapeutic options are also contributing to the growth in this region.

 

North America is anticipated to generate the highest demand during the forecast period in the dyslexia treatment and diagnosis market.  It is because of well-established healthcare infrastructure, high awareness levels, and early adoption of advanced diagnostic technologies. The strong government support for special education programs, high healthcare expenditure, and presence of leading market players is also adding strength to the accessibility of treatment solutions. In addition, widespread screening programs and a sound reimbursement environment are also supporting market dominance in the region.

 

 

Top 10 trends in the dyslexia treatment and diagnosis market

• AI-Driven Diagnostic Tools
• Early Intervention and Screening Focus
• Digital Therapeutic & App-Based Treatment
• Virtual Reality (VR) in Therapy
• Multisensory & Structured Literacy Programs
• Expansion of Teletherapy Services
• Adult-Focused Specialized Treatment
• Updated Neurobiological Definitions & Criteria
• Home-Based Treatment Models
• Integration of Psychological Support

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Dyslexia Treatment and Diagnosis Market

 

1. AI-Driven Diagnostic Tools
   With technologies that analyze handwriting, speech patterns, and eye-tracking data to accurately identify dyslexia signs, artificial intelligence (AI) and machine learning are transforming diagnoses.
    
2. Early Intervention and Screening Focus
   In order to detect learning problems early and provide prompt phonological and literacy support, educational systems are increasingly using early screening methods, frequently in kindergarten.
    
3. Digital Therapeutic & App-Based Treatment
   Evidence-based digital tools and gamified apps that use interactive, customized activities to enhance reading, spelling, and cognitive abilities are becoming more and more popular.
    
4. Virtual Reality (VR) in Therapy
   Virtual reality (VR) is becoming a potent, captivating tool for creating safe, immersive reading environments that boost motivation, offer instant feedback, and assist kids in practicing literacy skills in an enjoyable, non-threatening way.
    
5. Multisensory & Structured Literacy Programs
   Multisensory approaches that use visual, auditory, and kinesthetic pathways as well as structured literacy (such as the Orton-Gillingham approach) are being improved and incorporated into digital technologies.

 

Top 20 Companies Leading the dyslexia treatment and diagnosis market

1. Pfizer Inc.
2. Novartis AG
3. Eli Lilly and Company
4. GSK plc
5. Teva Pharmaceutical Industries Ltd.
6. Takeda Pharmaceutical Company Limited
7. Sun Pharmaceutical Industries Ltd.
8. Endo Pharmaceuticals Inc.
9. Apotex Corporation
10. Purdue Pharma
11. Pearson plc
12. Lindamood-Bell Learning Processes
13. Kurzweil Education
14. Learning Ally
15. Nessy Learning
16. Dybuster
17. Dynaread Special Education Corporation
18. Iansyst Ltd
19. Speechify Inc.
20. Oswald Labs

 

1. Pfizer Inc.
   Headquarters: New York City
   The Pfizer Inc., was founded in 1849, is a global pharmaceutical company with about 75,000 to 81,000 employees. Pfizer generated a revenue of about USD 62.6 billion in 2025. Pfizer’s product line includes vaccines, neurological care, specialty care, and cognition therapies, which indirectly contributes to dyslexia management through neurodevelopmental and mental health treatment solutions in the global dyslexia treatment and diagnosis market.
    
2. Novartis AG
   Headquarters: Basel
   The Novartis AG, company was established in 1996, has about 75,000-77,000 employees worldwide. The company's revenue was about USD 54.5 billion in 2025, mainly contributed by the strong performance of innovative medicines. The company’s products include prescription medicines, generics, and advanced therapies in neuroscience and cognitive health, indirectly contributing to the diagnosis and treatment of dyslexia through neurodevelopmental and mental health products in the global market.
    
3. Eli Lilly and Company
   Headquarters: Indianapolis, Indiana
   The Eli Lilly and Company, was founded in 1876, is a leading global pharmaceutical company with around 50,000 employees. The company has reported revenue of nearly USD 65.2 billion in 2025. The company has shown significant commercialization of innovative therapies. The company's research and development portfolio include research in the central nervous system and neurodevelopmental research areas. This has helped the company contribute significantly to the global dyslexia treatment and diagnosis market.
    
4. GSK plc
   Headquarters: London, United Kingdom
   The GSK plc, which was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, has about 66,000 employees worldwide. The organization makes about £32.7 billion in revenue every year (approximately USD 42.4 billion in revenue for the year 2025). The organization's vaccine, CNS therapies, and specialty products support neurodevelopmental research, which allows for strategic contributions to the global dyslexia treatment and diagnosis market through innovation in cognitive health and diagnostic advancements.
    
5. Teva Pharmaceutical Industries Ltd.
   Headquarters: Tel Aviv, Israel
   Teva Pharmaceutical Industries Ltd., company was established in 1901, is a leading global generics and specialty pharmaceutical company with about 37,000 employees worldwide. The organization reported a revenue of about USD 16.5 billion in 2025. The organization’s drug portfolio, including central nervous system agents, helps in the accessibility of neurodevelopmental care, hence contributing to the global dyslexia treatment and diagnosis market with affordable therapeutic options in the healthcare industry.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Dyslexia Treatment and Diagnosis Market

 

Are you ready to discover more about the dyslexia treatment and diagnosis market?

The report provides an in-depth analysis of the leading companies operating in the global dyslexia treatment and diagnosis market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

Company Profiles

1. Pfizer Inc.

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

2. Novartis AG
3. Eli Lilly and Company
4. GSK plc
5. Teva Pharmaceutical Industries Ltd.
6. Takeda Pharmaceutical Company Limited
7. Sun Pharmaceutical Industries Ltd.
8. Endo Pharmaceuticals Inc.
9. Apotex Corporation
10. Purdue Pharma
11. Pearson plc
12. Lindamood-Bell Learning Processes
13. Kurzweil Education
14. Learning Ally
15. Nessy Learning
16. Dybuster
17. Dynaread Special Education Corporation
18. Iansyst Ltd
19. Speechify Inc.
20. Oswald Labs

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Dyslexia Treatment and Diagnosis Market

 

Conclusion

The global dyslexia treatment and diagnosis market is estimated to rise from USD 28.91 billion in 2024 to USD 64.83 billion in 2035 at a CAGR of 7.62 percent due to increased awareness and early detection campaigns and a large patient pool of 780 million individuals worldwide. In addition, the increased use of AI-based diagnostic tools and digital and remote therapy will help scale up this market in the coming years. Currently, North America leads in this market due to well-developed infrastructure and supportive policies, while Asia Pacific is witnessing high growth due to increased healthcare investments in this region. Moreover, innovation in this sector and high participation from pharmaceutical and ed-tech companies will provide a boost to this market in the coming years.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter